Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Eli Lilly and Company (NYSE:LLY) Stock Rating Lowered by Wall Street Zen
Wall Street Zen has downgraded Eli Lilly and Company’s stock rating from “strong-buy” to “buy” despite recent positive developments like the FDA approval of Foundayo and strong quarterly earnings. The article also notes other analyst actions, current stock performance data, and significant institutional investor activity. While Eli Lilly continues to expand its pipeline with acquisitions and new drug approvals, competitive pressures and broader market risks are highlighted.